kez (ketoconazole) is a medicated dandruff shampoo used to treat fungal infections affecting the skin and scalp, for mild to severe conditions.
It’s available over-the-counter from leading pharmacies, without a prescription. It is suitable for all hair types.
kez is used for the treatment of infections of the skin and scalp associated with the fungus Malassezia (Pityrosporum), including:
• Seborrhoeic dermatitis
• Pityriasis capitis (dandruff)
• Pityriasis versicolor
It is the only medicated shampoo indicated for the treatment of Malassezia in South Africa.
A skin disorder affecting the scalp, face, and trunk.
When seborrhoeic dermatitis appears on a teenager’s or adult’s scalp, it’s called dandruff/ pityriasis capitis.
A common fungal infection of the skin. The fungus interferes with the normal pigmentation of the skin, resulting in small, discoloured patches.
Apply kez to the affected areas of the wet skin or wet hair and rub in lightly. Leave on for 3 to 5 minutes before rinsing thoroughly.
• Seborrhoeic dermatitis and pityriasis capitis: Use twice weekly (every 3 to 4 days) for 2 to 4 weeks.
• Pityriasis versicolor: Use once daily for a maximum of 5 days.
If you use kez after prolonged treatment with topical corticosteroids (corticosteroid cream), irritation may occur. To stop your condition from flaring up (rebound), after stopping prolonged topical corticosteroid treatment, the following is recommended:
• Continue applying a mild topical corticosteroid in the morning and apply kez in the evening,
• Subsequently, and gradually, withdraw the corticosteroid therapy over a 2 to 3-week period.
These articles are for information purposes only. It cannot replace the diagnosis of a healthcare provider. Pharma Dynamics gives no warranty as to the accuracy of the information contained in such articles and shall not, under any circumstances, be liable for any consequences which may be suffered as a result of a user’s reliance thereon.
The information the reader is about to be referred to may not comply with the South Africa regulatory requirements. Information relevant to the South African environment is available from the Company and in the Professional Information/Patient Information Leaflet/Instructions for Use approved by the Regulatory Authority
